脑动极光-B(06681)股东将股票存入香港上海汇丰银行 存仓市值7.42亿港元

Core Viewpoint - The latest data from the Hong Kong Stock Exchange indicates that shareholders of Brainstorm Cell Therapeutics-B (06681) deposited shares worth HKD 742 million into HSBC Hong Kong, representing 8.13% of the total [1] Financial Performance - For the six months ending June 30, 2025, Brainstorm Cell Therapeutics reported revenue of HKD 100 million, reflecting a year-on-year increase of 92.82% [1] - The adjusted net loss for the company was HKD 88.022 million, which is an increase of 11.64% compared to the previous year [1] - The loss attributable to the company's owners was HKD 126 million, marking a year-on-year increase of 10.53% [1] - The loss per share was HKD 0.11 [1]